Open Government Portal
Found 10 records similar to Biotechnology use and development survey, indicators for innovative biotechnology firms by region
Biotechnology use and development survey, indicators for innovative biotechnology firms by firm size
Biotechnology use and development survey, indicators for innovative biotechnology firms by firms size for Canada, biennial survey from 1999 to 2005.
Biotechnology use and development survey, indicators for innovative biotechnology firms by sector, for Canada, biennial survey from 1999 to 2005.
Innovation, selected service industries, percentage of business units that provided products to biotechnology or nanotechnology firms or organizations by type of business unit, technology firms or organizations and North American Industry Classification System (NAICS) for Canada, provinces and territories in 2003. (Terminated)
Survey of advanced technology, adoption of biotechnology, by North American Industry Classification System (NAICS) and enterprise size for Canada and certain provinces, in 2014.
Survey of advanced technology, applications related to biotechnology, by North American Industry Classification System (NAICS) and enterprise size for Canada and certain provinces, in 2014.
Survey of advanced technology, alliances or collaborative arrangements related to biotechnology, by North American Industry Classification System (NAICS) and enterprise size for Canada and certain provinces, in 2014.
Survey of advanced technology, main challenges in using or developing biotechnologies, by North American Industry Classification System (NAICS) and enterprise size for Canada and certain provinces, in 2014.
Survey of advanced technology, key driver in using or developing biotechnologies, by North American Industry Classification System (NAICS) and enterprise size for Canada and certain provinces, in 2014.
Health Canada shares the responsibility with Environment Canada for the risk assessment of new animate products of biotechnology including micro-organisms.
This guidance document applies to sponsors intending to make changes to new drugs that have received a NOC pursuant to Section C.08.004 of the Food and Drug Regulations. This may include pharmaceuticals, biologics and radiopharmaceuticals for human use and pharmaceutical, radiopharmaceutical and certain biotechnological products for veterinary use.